VRDN

Viridian Therapeutics, Inc.\DE

Healthcare · Biotechnology

$149.88 sample

+1.51 (+1.02%) 1D

Market cap

$757.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-05

Alerts

8

Price$149.88 -4.75% 3M daily closessample

159.40141.99

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: 10% owner
Oct 05SEC8-K filed: material event
Sep 28SECForm 144 filed
Sep 22INSInsider buy: Director
Sep 16INSInsider buy: Chief Executive Officer
Sep 10INSInsider sell: Chief Executive Officer
Sep 02INSInsider sell: Chief Executive Officer
Aug 25INSInsider sell: 10% owner

Sign up to see the real VRDN record →

Company facts

SEC EDGAR registration

Name: Viridian Therapeutics, Inc.\DE
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +38sample, -100 to +100
Reporting currency: USD

Who is positioning in VRDN

sample

Insiders: 20 insider transactions over 90 days, net selling, $435.5M
Congress: 1 members traded over 90 days
Institutions · 13F: 22 funds hold $5.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$26.5B +11.6% y/y

Q4 2024Q3 2026

Inventory$16.7B +14.1% y/y

Q4 2024Q3 2026

Accounts receivable$12.2B +10.4% y/y

Q4 2024Q3 2026

Total debt$32.2B +10.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $564.0B +14.5% 3M
Sample peer B: $723.2B +7.4% 3M
Sample peer C: $152.2B -0.1% 3M
Sample peer D: $308.0B +10.1% 3M
Sample peer E: $269.9B -12.2% 3M